b
r
c
sarscov
pro
play
import
role
viral
replic
studi
perform
biolog
evalu
nine
phlorotannin
isol
edibl
brown
alga
ecklonia
cava
nine
isol
phlorotannin
except
phloroglucinol
possess
sarscov
pro
inhibitori
activ
dosedepend
competit
manner
phlorotannin
two
eckol
group
diphenyl
ether
link
dieckol
show
potent
sarscov
pro
transciscleavag
inhibitori
effect
ic
lm
respect
first
report
phlorotannin
chemotyp
significantli
block
cleavag
sarscov
pro
cellbas
assay
toxic
furthermor
dieckol
exhibit
high
associ
rate
spr
sensorgram
form
extrem
strong
hydrogen
bond
catalyt
dyad
sarscov
pro
brown
alga
long
use
tradit
foodstuff
folk
medicin
asian
countri
recent
commerci
avail
ecklonia
cava
extract
approv
new
dietari
ingredi
ndi
us
food
drug
administr
fda
marin
alga
identifi
rich
sourc
structur
divers
bioactiv
compound
great
pharmaceut
biomed
potenti
eckolina
cava
laminariacea
edibl
brown
alga
grow
abundantli
subtid
region
jeju
island
korea
e
cava
use
produc
food
ingredi
anim
feed
fertil
folk
gynecopath
medicin
e
cava
contain
varieti
compound
includ
carotenoid
fucoidan
phlorotannin
show
differ
biolog
activ
phlorotannin
compon
oligomer
polyphenol
phloroglucinol
unit
respons
pharmacolog
activ
e
cava
ecklonia
speci
use
extens
tradit
medicin
treatment
goiter
scrofula
urinari
diseas
stomach
ailment
hemorrhoid
boil
constip
postpartum
women
previou
studi
present
wealth
evid
show
e
cava
exhibit
antioxid
anticanc
immunomodulatori
tyrosinas
inhibitori
activ
e
cava
also
exhibit
antiviru
activ
revers
transcriptas
influenza
viru
neuraminidas
howev
best
knowledg
report
phlorotannin
e
cava
elicit
sever
acut
respiratori
syndrom
coronaviru
sarscov
proteinas
pro
inhibitori
activ
sar
lifethreaten
form
atyp
pneumonia
caus
infect
novel
human
coronaviru
sarscov
pro
chymotrypsinlik
cystein
proteinas
essenti
viral
replic
recogn
key
target
antisar
drug
design
activ
site
sarscov
pro
contain
catalyt
dyad
compos
cystein
residu
act
nucleophil
histidin
residu
act
gener
acidbas
proteolyt
process
sarscov
pro
inhibitor
report
synthet
peptidyl
compound
librari
natur
productderiv
librari
synthet
inhibitori
compound
includ
c
symmetr
diol
quinolinecarboxyl
acid
anilid
naturalderiv
inhibitor
includ
betulin
acid
indigo
aloeemodin
quinonemethid
triterpenoid
biflavonoid
amentoflavon
aim
present
studi
investig
sarscov
pro
inhibitor
isol
e
cava
character
antisarscov
pro
effect
isol
phlorotannin
e
cava
use
cellfre
cleavag
cellbas
cleavag
assay
examin
transcleavag
sarscov
pro
cellfre
assay
proteolyt
activ
pro
test
fluorogen
substrat
dabcylktsavlqsgfrkmeedan
analyz
fluoresc
reson
energi
transfer
fret
assay
ciscleavag
sarscov
pro
determin
cellbas
assay
infram
construct
pro
substrat
savlqsgfrk
luciferas
luc
transfect
vero
cell
ciscleavag
activ
sarscov
pro
determin
use
luciferas
assay
also
assess
effect
inhibitor
sarscov
pro
interact
use
surfac
plasmon
reson
spr
analysi
bind
model
prepar
sarscov
pro
effect
isol
phlorotannin
sarscov
pro
transcleavag
assay
numer
function
requisit
role
cystein
proteas
viral
replic
pathogenesi
may
serv
attract
target
antivir
drug
sever
acut
respiratori
syndrom
sar
coronaviru
cov
depend
chymotrpsinlik
cystein
proteas
pro
process
translat
polyprotein
function
viral
protein
enzym
target
potenti
antisar
drug
ultim
goal
develop
natur
deriv
sarscov
pro
inhibitor
use
antisar
drug
first
step
toward
goal
express
purifi
sarscov
pro
e
coli
codonplusril
cell
describ
section
purifi
proteas
ran
approxim
kda
sodium
dodecyl
sulfacepolyacrylamid
gel
electrophoresi
sdspage
greater
puriti
purifi
pro
escherichia
coli
cell
specif
activ
lm
toward
dabcylktsavlqsgfrkmeedan
substrat
bioassayguid
investig
ethanol
extract
ecklonia
cava
result
isol
nine
phlorotannin
phloroglucinol
triphloretol
eckol
dioxinodehydroeckol
fucodiphloroethol
g
dieckol
phlorofucofuroeckol
fig
first
examin
effect
nine
phlorotannin
cellfre
sarscov
pro
transcleavag
assay
percent
inhibit
lm
concentr
compound
initi
determin
result
report
tabl
shown
tabl
figur
phlorotannin
investig
except
phloroglucinol
exhibit
dosedepend
inhibitori
effect
pro
hydrolysi
ic
valu
rang
lm
cellfre
pro
transcleavag
concentr
inhibitor
increas
residu
sarscov
pro
activ
decreas
dramat
inhibitor
exhibit
similar
relationship
enzym
activ
enzym
concentr
exampl
relev
data
dieckol
illustr
figur
inhibit
activ
slightli
affect
subtl
chang
structur
initi
compar
closedchain
trimer
phloroglucinol
eckol
openedchain
trimer
phloroglucinol
triphloretol
found
activ
eckol
ic
lm
higher
trimer
ic
lm
replac
group
dioxinodehydro
group
ic
lm
led
weaker
inhibit
compar
howev
still
activ
similar
relationship
substitut
group
openedchain
trimer
form
biaryl
linkag
tend
increas
activ
ic
lm
vs
ic
lm
howev
substitut
group
eckol
yield
tetremer
phlorotannin
reduc
activ
compar
seri
phloroeckol
found
introduct
substitu
group
phloro
increas
inhibitori
activ
ic
lm
ic
lm
interestingli
block
one
hydroxi
unit
ring
contain
fivememb
close
ring
appear
exert
variabl
ic
lm
insignific
effect
activ
evidenc
sarscov
pro
inhibit
data
eckol
structur
essenti
crucial
good
inhibit
pro
importantli
found
dieckol
possess
two
eckol
group
link
diphenyl
ether
show
potent
sarscov
pro
inhibitori
activ
ic
lm
addit
inhibitori
effect
dieckol
compar
natur
deriv
quinonemethid
triterpen
ic
lm
isol
previou
investig
pro
inhibitor
tripterygium
regelii
dieckol
show
greater
activ
posit
control
hesperetin
lm
daidzein
lm
aloeemodin
lm
respect
previous
report
lin
cowork
best
knowledg
first
report
biolog
activ
phlorotannin
isol
e
cava
toward
sarscov
pro
next
studi
kinet
mechan
interact
inhibitor
sarscov
pro
enzymat
activ
measur
seri
substrat
concentr
variou
inhibitor
concentr
inhibit
data
global
fit
possibl
kinet
model
shown
figur
kinet
plot
show
dieckol
competit
inhibit
profil
lineweaverburk
plot
vs
seri
straight
line
yaxi
intercept
sarscov
pro
inhibitor
isol
inhibitor
exhibit
mode
action
inhibit
k
valu
tabl
calcul
dixon
plot
use
determin
k
valu
inhibitor
see
supplementari
data
fig
predomin
inhibit
mode
shown
natur
occur
viral
enzym
inhibitor
noncompetit
interestingli
inhibit
sarscov
pro
phlorotannin
isol
e
cava
rare
competit
encourag
us
investig
phenomenon
detail
biolog
studi
subsequ
perform
cellbas
ciscleavag
assay
confirm
inhibitori
activ
isol
phlorotannin
sarscov
pro
test
phlorotannin
except
exhibit
dosedepend
cellbas
sarscov
pro
ciscleavag
inhibitori
activ
cellbas
cleavag
assay
isol
phlorotannin
inhibit
ciscleavag
activ
sarscov
pro
ic
valu
rang
lm
fig
tabl
dosedepend
manner
moreov
phlorotannin
nontox
vero
cell
cc
valu
greater
lm
activ
phlorotannin
less
effect
evalu
sarscov
pro
ciscleavag
assay
evalu
cellfre
transcleavag
assay
explan
result
may
sever
compound
permeat
cellular
membran
reach
intracellular
sarscov
pro
cellbas
assay
indic
dieckol
ic
lm
effici
block
cleavag
process
pro
agre
cellfre
cleavag
fret
assay
data
dieckol
show
strong
correl
effect
cellfre
cellbas
cleavag
sarscov
pro
particular
dieckol
effici
block
cleavag
pro
indigo
sinigrin
betasitosterol
aloeemodin
previous
report
plantderiv
phenol
compound
although
diekcol
consider
less
effect
hesperetin
ic
lm
first
report
phlorotannin
chemotyp
dieckol
significantli
block
cleavag
sarscov
pro
surfac
plasmon
reson
spr
use
techniqu
monitor
molecular
reaction
realtim
use
determin
bind
specif
well
rate
associ
dissoci
ligand
protein
studi
sarscov
pro
immobil
sensor
chip
potent
pro
inhibitor
dieckol
isol
e
cava
pass
sensor
surfac
analyz
whether
dieckol
interact
due
specif
bind
event
spr
sensorgram
compound
record
sever
differ
concentr
bind
respons
reson
unit
ru
continu
record
present
graphic
function
time
associ
describ
simpl
equilibrium
b
ab
type
analyt
b
ligand
ab
complex
spr
sensorgram
use
determin
kinet
bind
paramet
associ
rate
constant
k
lm
dissoci
rate
constant
k
sarscov
pro
diekcol
increas
spr
sensorgram
signific
dosedepend
manner
fig
dissoci
constant
k
k
k
calcul
global
fit
kinet
data
variou
dieckol
promis
result
outlin
encourag
us
investig
princip
interact
phlorotannin
sarscov
pro
gain
insight
inhibit
mechan
dock
experi
perform
potent
inhibitor
sarscov
pro
dieckol
analyz
molecular
dock
analysi
interact
protein
residu
origin
ligandbind
site
structur
sarscov
pro
complex
inhibitor
code
obtain
protein
data
bank
pdb
http
wwwrcsborg
pdb
use
model
analysi
conform
analysi
conduct
use
autodock
power
conform
search
capabl
phlorotannin
identifi
competit
inhibitor
transciscleavag
assay
sarscov
pro
fit
substratebind
pocket
pocket
enzym
dock
simul
result
simul
show
test
compound
dock
energi
rang
kcalmol
see
supplementari
data
tabl
poignantli
dieckol
possess
two
eckol
group
link
diphenyl
ether
show
lowest
bind
energi
kcal
mol
previous
found
eckol
structur
essenti
crucial
good
inhibit
sarscov
pro
shown
figur
hydroxyl
group
dieckol
form
hydrogen
bond
hydroxyl
group
form
hydrogen
bond
addit
hydroxyl
group
form
hydrogen
bond
hydroxyl
group
dieckol
form
two
hbond
catalyt
residu
sarscov
pro
simul
dock
interact
dieckol
amino
acid
residu
activ
site
pro
reveal
dieckol
bound
site
sarscov
pro
hbond
addit
confirm
dieckol
form
especi
strong
hydrogen
bond
catalyt
dyad
sarscov
pro
dock
experi
support
infer
drawn
enzymat
assay
reveal
import
inhibitori
action
dieckol
sarscov
pro
studi
report
first
time
phloratannin
e
cava
competit
inhibit
sarscov
pro
cellfreebas
system
inhibit
activ
phlorotannin
pro
assess
cellfreebas
analysi
confirm
fret
luciferas
result
evalu
bind
affin
phlorotannin
isol
e
cava
pro
spr
analysi
molecular
bind
studi
phlorotannin
except
phloroglucinol
show
dose
potent
inhibitori
activ
cellbas
pro
ciscleavag
assay
potenc
greater
phlorotannin
deriv
natur
refer
inhibitor
addit
detail
proteininhibitor
bind
affin
analys
spr
molecular
dock
simul
dieckol
unveil
high
associ
rate
form
strong
hydrogen
bond
catalyt
dyad
sarscov
pro
lowest
bind
energi
dri
powder
brown
alga
ecklonia
cava
kg
extract
ethanol
l
week
room
temperatur
concentr
extract
g
suspend
h
l
aqueou
layer
partit
sequenti
nhexan
l
ethyl
acet
l
water
obtain
ethyl
acet
layer
g
chromatograph
silica
gel
use
chloroform
methanol
vv
gradient
produc
fraction
fr
fraction
fr
repeatedli
subject
silica
gel
column
chromatographi
use
mixtur
chloroform
methanol
vv
give
fraction
fr
dioxinodehydroeckol
purifi
subfract
fr
mplc
use
gradient
solvent
system
contain
chloroform
methanol
vv
triphloretola
dieckol
obtain
purifi
fraction
fr
use
column
chromatographi
mixtur
water
methanol
vv
fraction
fr
purifi
silica
gel
column
use
gradient
solvent
system
contain
chloroform
methanol
vv
yield
fraction
fr
base
tlc
analysi
phlorofucofuroeckol
purifi
mplc
use
chloroform
methanol
solvent
mixtur
vv
obtain
subfract
fr
fraction
fr
subject
column
chromatographi
use
water
methanol
vv
give
fucodiphloroethol
g
eckol
base
tlc
analysi
fraction
fr
repurifi
column
methanol
two
compound
obtain
phloroglucinol
result
supernat
appli
nickelaffin
chromatographi
throughout
procedur
protein
final
column
fraction
dialyz
overnight
mm
trishcl
buffer
ph
mm
dithiothreitol
store
enzym
concentr
determin
spectrophotometr
nm
use
biorad
protein
assay
puriti
molecular
weight
sarscov
pro
verifi
sdspage
purifi
proteas
ran
approxim
calcul
size
kda
sdspage
sarscov
pro
transcleavag
assay
describ
inhibitori
effect
compound
sarscov
pro
measur
use
fret
method
assay
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
anygen
co
republ
korea
use
substrat
enzym
activ
determin
measur
increas
fluoresc
continu
monitor
reaction
nm
excit
nm
use
fluoresc
plate
reader
bioteck
instrument
inc
usa
ic
valu
isol
compound
measur
reaction
mixtur
contain
lgml
pro
final
concentr
lg
test
compound
lm
lm
fluorogen
peptid
substrat
mm
bistri
buffer
ph
determin
enzym
activ
experiment
data
fit
logist
curv
eq
timedr
protocol
use
initi
veloc
record
rang
concentr
data
analyz
use
nonlinear
regress
program
sigma
plot
spcc
inc
chicago
il
c
fluoresc
control
enzym
buffer
substrat
min
incub
c
fluoresc
control
min
fluoresc
test
sampl
enzym
sampl
solut
substrat
incub
fluoresc
test
sampl
min
studi
kinet
sarscov
pro
inhibit
isol
compound
variou
concentr
compound
ad
pro
assay
buffer
contain
predetermin
substrat
k
valu
calcul
nonlinear
regress
analysi
fit
differ
model
enzym
inhibit
kinet
data
use
sigmaplot
enzym
kinet
modul
spss
inc
chicago
il
inhibit
mechan
compound
determin
compar
statist
result
includ
akaik
inform
criterion
valu
differ
inhibit
model
select
one
best
fit
cellbas
ciscleavag
assay
infram
construct
pro
substrat
luciferas
form
plasmid
pro
sluc
construct
plasmid
dna
transfect
vero
cell
lipofectamin
accord
manufactur
instruct
invitrogen
usa
transfect
cell
incub
dulbecco
modifi
eagl
medium
dmem
contain
bovin
serum
fb
h
co
atmospher
media
remov
replac
dmem
contain
test
compound
differ
concentr
h
incub
activ
luciferas
cell
lysat
measur
use
dual
luciferas
report
assay
system
promega
usa
luminomet
centro
xs
lb
berthold
technolog
inc
greater
kda
protein
fuse
nterminu
luciferas
remark
decreas
luciferas
activ
detect
luciferas
activ
consid
measur
ciscleavag
sarscov
pro
realtim
analysi
ligand
interact
sarscov
pro
surfac
plasmon
reson
spr
spr
measur
perform
reichert
spr
instrument
kindli
provid
loan
woojung
bsc
inc
enzym
dialyz
pb
buffer
prior
immobil
surfac
activ
min
inject
edcsulfonh
mixtur
mm
concentr
protein
dilut
lgml
mm
acet
buffer
ph
inject
min
activ
site
quench
ethanolamin
buffer
ph
wash
phosphatebuff
salin
ph
pb
bind
surfac
stabil
blank
inject
pb
pb
use
run
sampl
dilut
buffer
experi
test
inhibitor
first
prepar
mm
stock
solut
dimethyl
sulfoxid
dmso
dilut
pb
immedi
prior
experi
analyt
bind
analyz
use
autom
run
twofold
dilut
seri
two
zero
concentr
inject
regener
step
perform
use
mm
naoh
data
analyz
softwar
referenc
blank
bind
dissoci
curv
fit
global
twostat
bind
kinet
model
dock
experi
conduct
use
autodock
lamarckian
genet
algorithm
lga
coordin
xray
crystal
structur
sarscov
pro
pdb
access
code
obtain
protein
data
bank
pdb
http
wwwpdborg
use
dock
studi
remov
water
molecul
polar
hydrogen
h
atom
ad
macromolecul
histidin
residu
made
neutral
kollman
charg
assign
atom
atom
coordin
compound
gener
corina
program
molecular
network
gmbh
erlangen
germani
autodock
version
use
comput
molecular
dock
simul
flexibl
small
molecul
rigid
protein
dock
result
rank
accord
dock
energi
score
chimera
softwar
program
univers
california
san
francisco
use
identifi
potenti
hbond
residu
activ
site
pocket
sarscov
pro
